本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Madrigal Pharmaceuticals, Inc.

523.26
-16.8000-3.11%
盤後523.260.00000.00%19:30 EDT
成交量:25.94萬
成交額:1.35億
市值:120.64億
市盈率:-36.81
高:539.71
開:539.25
低:513.36
收:540.06
52周最高:615.00
52周最低:393.61
股本:2,305.55萬
流通股本:1,372.50萬
量比:1.23
換手率:1.89%
股息:- -
股息率:- -
每股收益(TTM):-14.2164
每股收益(LYR):-12.8501
淨資產收益率:-53.31%
總資產收益率:-17.84%
市淨率:23.04
市盈率(LYR):-40.72

資料載入中...

2023/06/20

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/03

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/23

重要事件披露

8-K - Current report
2023/02/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

重要事件披露

8-K - Current report
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/10

重要事件披露

8-K - Current report
2022/12/23

重要事件披露

8-K - Current report
2022/12/19

重要事件披露

8-K - Current report
2022/11/03

重要事件披露

8-K - Current report
2022/11/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]